UKA for Knee

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Knee+2 More
Total knee arthroplasty - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial finds that for patients with medial compartment osteoarthritis, UKA results in better function and less pain than TKA.

Eligible Conditions
  • Knee

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 2 years

2 years
Knee Society Score
Revision

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

UKA
1 of 2
TKA
1 of 2

Active Control

112 Total Participants · 2 Treatment Groups

Primary Treatment: UKA · No Placebo Group · N/A

UKA
Procedure
ActiveComparator Group · 1 Intervention: Unicompartmental knee arthroplasty · Intervention Types: Procedure
TKA
Procedure
ActiveComparator Group · 1 Intervention: Total knee arthroplasty · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Anderson Orthopaedic Research InstituteLead Sponsor
13 Previous Clinical Trials
1,508 Total Patients Enrolled
Rush University Medical CenterOTHER
382 Previous Clinical Trials
151,145 Total Patients Enrolled
Kevin Fricka, MDPrincipal InvestigatorAnderson Orthopaedic Institute

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a varus deformity of less than 20 degrees.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: November 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
District of Columbia100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Anderson Orthopaedic Research Institute100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%